Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Checkpoint kinase 2 pseudogene 4 (CHEK2P4)
- Target
- CHEK2P4
- Molecular classification
- Other: Pseudogene, non-protein-coding DNA sequence
01
Overview
Checkpoint kinase 2 pseudogene 4 (CHEK2P4) is a non-protein-coding pseudogene located within the human genome, sharing sequence homology to the active CHEK2 gene but not expressed as a functional protein. Unlike CHEK2, which encodes a serine/threonine kinase critical for DNA damage response and cell cycle control, CHEK2P4 does not participate in any known biological pathways, is not a therapeutic target, and is neither implicated in disease nor targeted by drugs. CHEK2P4 is one of several non-functional duplications derived from the CHEK2 gene, with no documented roles in human health or disease
- Other names
- CHEK2P4Checkpoint kinase 2 pseudogene 4
02
Mechanism of action
None. No mechanism of action applies to CHEK2P4, as it is not a target for pharmacological intervention
03
Biological functions
Other: No known biological function. CHEK2P4 does not encode an active protein and is not implicated in any cellular processes. By contrast, the functional CHEK2 gene is involved in DNA damage response, cell cycle checkpoint regulation, and tumor suppression
04
Disease associations
None specific. There are no documented disease associations for CHEK2P4. All described pathogenic roles (such as cancer predisposition or cell cycle checkpoint defects) relate to CHEK2 and not the pseudogene CHEK2P4
05
Safety considerations
None. There are no safety concerns related to CHEK2P4 in therapy, diagnosis, or research, owing to its lack of function
06
Interacting drugs
None. No drugs are known to interact with CHEK2P4. Therapeutic targeting and drug interactions are relevant only for the active kinase CHEK2
07
Biomarkers
None. CHEK2P4 has no known utility as a biomarker. Biomarker relevance applies to the functional CHEK2 gene and its mutations, not the pseudogene
Beyond the preview
Go deeper on Checkpoint kinase 2 pseudogene 4 (CHEK2P4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Checkpoint kinase 2 pseudogene 4 (CHEK2P4).